Pertussis diagnosis remains difficult to achieve because of the extrem
e variability of the clinical expression of the infection and because
of the absence of validated sensitive and specific biological method o
f confirmation. Sensitivity and specificity requirements are different
as may be in clinical practice, epidemiological surveillance or vacci
ne trials. For this reason, various case definitions are used without
any consensus. New technologies demonstrating both sensitivity and spe
cificity such as PCR may improve diagnosis in the future, simplify the
case definitions and hopefully will reach a consensus.